BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $642,000 | -10.3% | 4,250 | -13.5% | 0.00% | -25.0% |
| Q2 2022 | $716,000 | -8.7% | 4,911 | -25.7% | 0.00% | +33.3% |
| Q1 2022 | $784,000 | -13.4% | 6,608 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $905,000 | +96.3% | 6,568 | -2.7% | 0.00% | +50.0% |
| Q1 2021 | $461,000 | -56.6% | 6,750 | -45.6% | 0.00% | -60.0% |
| Q4 2020 | $1,063,000 | +31.7% | 12,405 | -0.1% | 0.01% | +25.0% |
| Q3 2020 | $807,000 | -1.1% | 12,420 | +11.2% | 0.00% | 0.0% |
| Q2 2020 | $816,000 | +170.2% | 11,165 | +25.7% | 0.00% | +100.0% |
| Q1 2020 | $302,000 | -37.5% | 8,880 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $483,000 | +47.3% | 8,880 | +13.1% | 0.00% | 0.0% |
| Q3 2019 | $328,000 | – | 7,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |